

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 6.60030832 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.47309239 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.47309239 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.47309239 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.47309239 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.47309239 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 6.47309239 |
| 8 | detection of molecule of bacterial origin (GO:0032490) | 6.14366054 |
| 9 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.79891213 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.60818454 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 5.51514807 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 5.44897212 |
| 13 | cellular extravasation (GO:0045123) | 5.27875734 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 5.24978358 |
| 15 | neutrophil mediated immunity (GO:0002446) | 5.13759704 |
| 16 | microglial cell activation (GO:0001774) | 5.02883651 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.93855458 |
| 18 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.87745120 |
| 19 | detection of external biotic stimulus (GO:0098581) | 4.67625912 |
| 20 | response to host immune response (GO:0052572) | 4.62959644 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.62959644 |
| 22 | detection of other organism (GO:0098543) | 4.60859379 |
| 23 | macrophage activation (GO:0042116) | 4.59691594 |
| 24 | negative regulation of cell killing (GO:0031342) | 4.52878252 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.52878252 |
| 26 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.51743952 |
| 27 | detection of biotic stimulus (GO:0009595) | 4.40672600 |
| 28 | myeloid leukocyte mediated immunity (GO:0002444) | 4.26491884 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 4.22393554 |
| 30 | respiratory burst (GO:0045730) | 4.21731465 |
| 31 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.19739617 |
| 32 | response to host (GO:0075136) | 4.19739617 |
| 33 | response to host defenses (GO:0052200) | 4.19739617 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.12803710 |
| 35 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 4.08515365 |
| 36 | neutrophil activation (GO:0042119) | 3.96534473 |
| 37 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.90517517 |
| 38 | detection of bacterium (GO:0016045) | 3.86638120 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.84504333 |
| 40 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.82410301 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.79377070 |
| 42 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.78801651 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.72244250 |
| 44 | granulocyte activation (GO:0036230) | 3.67941556 |
| 45 | negative regulation of T cell mediated immunity (GO:0002710) | 3.63129844 |
| 46 | leukocyte aggregation (GO:0070486) | 3.58424619 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.56732054 |
| 48 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.56622461 |
| 49 | regulation of growth of symbiont in host (GO:0044126) | 3.56622461 |
| 50 | negative regulation of growth of symbiont in host (GO:0044130) | 3.56622461 |
| 51 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.56622461 |
| 52 | defense response to protozoan (GO:0042832) | 3.55237035 |
| 53 | regulation of macrophage cytokine production (GO:0010935) | 3.54675230 |
| 54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.54009866 |
| 55 | cell wall macromolecule catabolic process (GO:0016998) | 3.50598410 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 3.50282637 |
| 57 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.47941257 |
| 58 | immunoglobulin mediated immune response (GO:0016064) | 3.47288881 |
| 59 | positive regulation of interferon-alpha production (GO:0032727) | 3.46375752 |
| 60 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.39897970 |
| 61 | regulation of interferon-alpha production (GO:0032647) | 3.38665560 |
| 62 | regulation of mast cell activation (GO:0033003) | 3.36972175 |
| 63 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.34001357 |
| 64 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.33702274 |
| 65 | positive regulation of mast cell activation (GO:0033005) | 3.26469480 |
| 66 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.26271348 |
| 67 | positive regulation of interferon-beta production (GO:0032728) | 3.24295048 |
| 68 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.20538289 |
| 69 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.20267096 |
| 70 | response to protozoan (GO:0001562) | 3.19001624 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18505263 |
| 72 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.18250274 |
| 73 | positive regulation of interleukin-1 production (GO:0032732) | 3.12810093 |
| 74 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.10148277 |
| 75 | T-helper 1 type immune response (GO:0042088) | 3.09015246 |
| 76 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.08666267 |
| 77 | positive regulation of macrophage cytokine production (GO:0060907) | 3.08480675 |
| 78 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.08003115 |
| 79 | negative regulation of interleukin-1 production (GO:0032692) | 3.05493296 |
| 80 | neutrophil chemotaxis (GO:0030593) | 3.04911106 |
| 81 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.04491265 |
| 82 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.03451415 |
| 83 | regulation of leukocyte degranulation (GO:0043300) | 3.02318778 |
| 84 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00514512 |
| 85 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.00386608 |
| 86 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.99982907 |
| 87 | negative regulation of interleukin-6 production (GO:0032715) | 2.98651560 |
| 88 | neutrophil migration (GO:1990266) | 2.97042325 |
| 89 | negative regulation of interleukin-17 production (GO:0032700) | 2.94596319 |
| 90 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.92672028 |
| 91 | positive regulation of mast cell degranulation (GO:0043306) | 2.92672028 |
| 92 | myeloid leukocyte activation (GO:0002274) | 2.91801512 |
| 93 | leukocyte degranulation (GO:0043299) | 2.89744530 |
| 94 | germinal center formation (GO:0002467) | 2.89095098 |
| 95 | reactive oxygen species biosynthetic process (GO:1903409) | 2.88073920 |
| 96 | regulation of interferon-beta production (GO:0032648) | 2.86911997 |
| 97 | regulation of tolerance induction (GO:0002643) | 2.86170088 |
| 98 | cell wall macromolecule metabolic process (GO:0044036) | 2.85742778 |
| 99 | cellular response to type I interferon (GO:0071357) | 2.84747148 |
| 100 | type I interferon signaling pathway (GO:0060337) | 2.84747148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.75448115 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.62901618 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.58575943 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.95317897 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.78756679 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.69234660 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58407116 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.58342907 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.35009227 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94029996 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.81519825 |
| 12 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.80616076 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.76219717 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.68888065 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.68840603 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.67138824 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.66533253 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.66384552 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62824904 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.60556996 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.54368845 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.44952715 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.42117684 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.27934923 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.25423336 |
| 26 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.13863879 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12792032 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12089611 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.11600238 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06781046 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03553905 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.03184371 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01089288 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98802566 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.93998017 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.85705792 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82825894 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.78845484 |
| 39 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.77311508 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71453323 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.67743652 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59951799 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.54541956 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49536731 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47283475 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46658567 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42647173 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39272644 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35328584 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30742726 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30291290 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29735045 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29113237 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28819222 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28690004 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.27342958 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22394950 |
| 58 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21325403 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20506888 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20459111 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20276834 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20182201 |
| 63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19813637 |
| 64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15398278 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14115391 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.13644239 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12454059 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11177019 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10496341 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07385842 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06822757 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05534858 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04319752 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02945188 |
| 75 | MYC_22102868_ChIP-Seq_BL_Human | 1.00568993 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98442812 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95443552 |
| 78 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93963352 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90932024 |
| 80 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.90802448 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90747443 |
| 82 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85994888 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85773056 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81737210 |
| 85 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.79487159 |
| 86 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.77228050 |
| 87 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74996874 |
| 88 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72589439 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71901366 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.71890424 |
| 91 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.70436242 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.69067526 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.68831589 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.68535217 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68486358 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.68246624 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66883085 |
| 98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.66465841 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65043767 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.65043601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.63500116 |
| 2 | MP0003436_decreased_susceptibility_to | 3.92495668 |
| 3 | MP0003303_peritoneal_inflammation | 3.88049813 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.74626569 |
| 5 | MP0002419_abnormal_innate_immunity | 3.33464675 |
| 6 | MP0009785_altered_susceptibility_to | 3.09389940 |
| 7 | MP0006082_CNS_inflammation | 2.94576612 |
| 8 | MP0005025_abnormal_response_to | 2.83642527 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.61686253 |
| 10 | MP0001800_abnormal_humoral_immune | 2.47313613 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.43569515 |
| 12 | MP0008260_abnormal_autophagy | 2.43491954 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.41749371 |
| 14 | MP0002723_abnormal_immune_serum | 2.39884612 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.34929930 |
| 16 | MP0000685_abnormal_immune_system | 2.32767428 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.26350877 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.25620598 |
| 19 | MP0009278_abnormal_bone_marrow | 2.25020193 |
| 20 | MP0009764_decreased_sensitivity_to | 2.23789168 |
| 21 | MP0001819_abnormal_immune_cell | 2.22957333 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.20802881 |
| 23 | MP0005671_abnormal_response_to | 2.18243075 |
| 24 | MP0003828_pulmonary_edema | 2.12334033 |
| 25 | MP0005387_immune_system_phenotype | 2.10344282 |
| 26 | MP0001790_abnormal_immune_system | 2.10344282 |
| 27 | MP0001545_abnormal_hematopoietic_system | 2.02791132 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 2.02791132 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.96625652 |
| 30 | MP0005451_abnormal_body_composition | 1.91540196 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.81990333 |
| 32 | MP0003075_altered_response_to | 1.74229343 |
| 33 | MP0002132_abnormal_respiratory_system | 1.74113600 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.73720613 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.73312545 |
| 36 | MP0000716_abnormal_immune_system | 1.64301576 |
| 37 | MP0004947_skin_inflammation | 1.62768386 |
| 38 | MP0005164_abnormal_response_to | 1.56495989 |
| 39 | MP0002405_respiratory_system_inflammati | 1.55871711 |
| 40 | MP0004883_abnormal_blood_vessel | 1.55299217 |
| 41 | MP0002398_abnormal_bone_marrow | 1.54371477 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.52020981 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.50213700 |
| 44 | MP0008469_abnormal_protein_level | 1.49316367 |
| 45 | MP0004381_abnormal_hair_follicle | 1.44875009 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.36946847 |
| 47 | MP0000858_altered_metastatic_potential | 1.35752165 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.35109883 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.33606571 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.30058367 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.28570368 |
| 52 | MP0001853_heart_inflammation | 1.28299250 |
| 53 | MP0002722_abnormal_immune_system | 1.27034017 |
| 54 | MP0008004_abnormal_stomach_pH | 1.26776040 |
| 55 | MP0005310_abnormal_salivary_gland | 1.26670314 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.26123380 |
| 57 | MP0002429_abnormal_blood_cell | 1.25620865 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.24296665 |
| 59 | MP0005166_decreased_susceptibility_to | 1.24116743 |
| 60 | MP0002006_tumorigenesis | 1.22725871 |
| 61 | MP0004510_myositis | 1.20310284 |
| 62 | MP0002332_abnormal_exercise_endurance | 1.16231519 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.14798621 |
| 64 | MP0003690_abnormal_glial_cell | 1.13832994 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.13013903 |
| 66 | MP0003011_delayed_dark_adaptation | 1.10100071 |
| 67 | MP0003866_abnormal_defecation | 1.05631019 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.01309501 |
| 69 | MP0003448_altered_tumor_morphology | 0.99942725 |
| 70 | MP0000343_altered_response_to | 0.98929700 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 0.98402839 |
| 72 | MP0000604_amyloidosis | 0.96947538 |
| 73 | MP0003183_abnormal_peptide_metabolism | 0.95144882 |
| 74 | MP0004484_altered_response_of | 0.92723988 |
| 75 | MP0003787_abnormal_imprinting | 0.92492786 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91639767 |
| 77 | MP0002009_preneoplasia | 0.89768451 |
| 78 | MP0003195_calcinosis | 0.89758539 |
| 79 | MP0000703_abnormal_thymus_morphology | 0.88786304 |
| 80 | MP0009763_increased_sensitivity_to | 0.88455514 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.85509281 |
| 82 | MP0001851_eye_inflammation | 0.84851847 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 0.84609002 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 0.84071555 |
| 85 | MP0009840_abnormal_foam_cell | 0.83733298 |
| 86 | MP0008877_abnormal_DNA_methylation | 0.83570449 |
| 87 | MP0005075_abnormal_melanosome_morpholog | 0.81532301 |
| 88 | MP0005390_skeleton_phenotype | 0.80336800 |
| 89 | MP0005174_abnormal_tail_pigmentation | 0.79866784 |
| 90 | MP0008874_decreased_physiological_sensi | 0.75196427 |
| 91 | MP0006054_spinal_hemorrhage | 0.68169449 |
| 92 | MP0000371_diluted_coat_color | 0.67589043 |
| 93 | MP0000249_abnormal_blood_vessel | 0.64388004 |
| 94 | MP0005266_abnormal_metabolism | 0.63007937 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.62280015 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.61218174 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.61178051 |
| 98 | MP0005076_abnormal_cell_differentiation | 0.60035450 |
| 99 | MP0001663_abnormal_digestive_system | 0.58361734 |
| 100 | MP0003045_fibrosis | 0.57496598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 6.15732856 |
| 2 | Optic neuritis (HP:0100653) | 5.99982779 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 5.99982779 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.95004291 |
| 5 | Orchitis (HP:0100796) | 5.90650017 |
| 6 | Myositis (HP:0100614) | 5.82642240 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.71040488 |
| 8 | Stomatitis (HP:0010280) | 5.50584984 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.50424119 |
| 10 | Abnormality of macrophages (HP:0004311) | 5.28283754 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.84984334 |
| 12 | Keratoconjunctivitis sicca (HP:0001097) | 4.34901344 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.34019698 |
| 14 | Amyloidosis (HP:0011034) | 4.17477495 |
| 15 | Keratoconjunctivitis (HP:0001096) | 4.05912918 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.01699146 |
| 17 | Recurrent skin infections (HP:0001581) | 4.01045183 |
| 18 | Obstructive lung disease (HP:0006536) | 3.92049571 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.92049571 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.74623329 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.74623329 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 3.70133517 |
| 23 | Hemoptysis (HP:0002105) | 3.66201047 |
| 24 | Meningitis (HP:0001287) | 3.64447695 |
| 25 | Spontaneous hematomas (HP:0007420) | 3.63645614 |
| 26 | Episodic fever (HP:0001954) | 3.58782059 |
| 27 | Gingivitis (HP:0000230) | 3.55074142 |
| 28 | Vasculitis (HP:0002633) | 3.52202954 |
| 29 | Encephalitis (HP:0002383) | 3.42513563 |
| 30 | Arterial thrombosis (HP:0004420) | 3.39644162 |
| 31 | Leukocytosis (HP:0001974) | 3.32627644 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.30366678 |
| 33 | Pulmonary infiltrates (HP:0002113) | 3.28505183 |
| 34 | Urticaria (HP:0001025) | 3.27030287 |
| 35 | Gangrene (HP:0100758) | 3.14797105 |
| 36 | Chest pain (HP:0100749) | 3.13327213 |
| 37 | Gingival bleeding (HP:0000225) | 3.11961683 |
| 38 | Peritonitis (HP:0002586) | 3.02690738 |
| 39 | Pulmonary embolism (HP:0002204) | 3.02052360 |
| 40 | Loss of speech (HP:0002371) | 2.89394652 |
| 41 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.84059877 |
| 42 | Increased IgE level (HP:0003212) | 2.79560309 |
| 43 | Granulocytopenia (HP:0001913) | 2.79501297 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.75677885 |
| 45 | T lymphocytopenia (HP:0005403) | 2.74023530 |
| 46 | Thrombocytosis (HP:0001894) | 2.72625308 |
| 47 | Abnormality of the pleura (HP:0002103) | 2.63411895 |
| 48 | Anorexia (HP:0002039) | 2.62689053 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.60840861 |
| 50 | Epistaxis (HP:0000421) | 2.60021267 |
| 51 | Eosinophilia (HP:0001880) | 2.58950734 |
| 52 | Polyneuropathy (HP:0001271) | 2.57256634 |
| 53 | Increased cerebral lipofuscin (HP:0011813) | 2.48354575 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47513124 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47513124 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47513124 |
| 57 | Recurrent viral infections (HP:0004429) | 2.46160088 |
| 58 | Petechiae (HP:0000967) | 2.44471974 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.43505171 |
| 60 | Glomerulopathy (HP:0100820) | 2.42571239 |
| 61 | Sepsis (HP:0100806) | 2.39928596 |
| 62 | Vertigo (HP:0002321) | 2.38632622 |
| 63 | Abnormality of the endocardium (HP:0004306) | 2.38285936 |
| 64 | Osteomyelitis (HP:0002754) | 2.37621240 |
| 65 | Periodontitis (HP:0000704) | 2.31727817 |
| 66 | Cellulitis (HP:0100658) | 2.30706275 |
| 67 | Abnormality of T cells (HP:0002843) | 2.23561659 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.15330355 |
| 69 | Acute hepatic failure (HP:0006554) | 2.11514089 |
| 70 | Thrombophlebitis (HP:0004418) | 2.10893428 |
| 71 | Increased IgM level (HP:0003496) | 2.10573606 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.08241232 |
| 73 | Abnormality of the pericardium (HP:0001697) | 2.07529750 |
| 74 | Keratitis (HP:0000491) | 2.07412736 |
| 75 | Inflammation of the large intestine (HP:0002037) | 2.07091910 |
| 76 | Hematochezia (HP:0002573) | 2.03671594 |
| 77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02383125 |
| 78 | Cheilitis (HP:0100825) | 1.99079980 |
| 79 | Skin rash (HP:0000988) | 1.98979604 |
| 80 | Abnormality of the peritoneum (HP:0002585) | 1.98637227 |
| 81 | Abnormality of eosinophils (HP:0001879) | 1.98342156 |
| 82 | Amaurosis fugax (HP:0100576) | 1.95889373 |
| 83 | Myocardial infarction (HP:0001658) | 1.95549542 |
| 84 | Hepatosplenomegaly (HP:0001433) | 1.95454236 |
| 85 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.92291969 |
| 86 | Fatigue (HP:0012378) | 1.91925866 |
| 87 | Skin ulcer (HP:0200042) | 1.90891369 |
| 88 | Subacute progressive viral hepatitis (HP:0006572) | 1.89223345 |
| 89 | Abnormality of T cell physiology (HP:0011840) | 1.88248045 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 1.88157557 |
| 91 | Increased serum ferritin (HP:0003281) | 1.87976217 |
| 92 | Vacuolated lymphocytes (HP:0001922) | 1.84266440 |
| 93 | Acne (HP:0001061) | 1.83817430 |
| 94 | Increased CSF protein (HP:0002922) | 1.82871709 |
| 95 | Alveolar cell carcinoma (HP:0006519) | 1.82027190 |
| 96 | Purpura (HP:0000979) | 1.77571960 |
| 97 | Dysostosis multiplex (HP:0000943) | 1.76635971 |
| 98 | Disinhibition (HP:0000734) | 1.75803709 |
| 99 | Hypochromic anemia (HP:0001931) | 1.75065807 |
| 100 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74620553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.45253335 |
| 2 | IRAK4 | 3.41081128 |
| 3 | BLK | 3.33560956 |
| 4 | TYK2 | 3.07780280 |
| 5 | MAP2K3 | 2.97336251 |
| 6 | CSK | 2.40754747 |
| 7 | MAP4K1 | 2.34249559 |
| 8 | TNK2 | 2.22075448 |
| 9 | BMPR2 | 2.21513732 |
| 10 | MAP3K14 | 2.12755209 |
| 11 | FES | 2.04582690 |
| 12 | ZAP70 | 2.03395333 |
| 13 | MAP3K3 | 1.99965118 |
| 14 | IKBKE | 1.99126783 |
| 15 | TXK | 1.92426704 |
| 16 | FGR | 1.90111529 |
| 17 | IRAK1 | 1.87847718 |
| 18 | MAP3K6 | 1.87645096 |
| 19 | IRAK2 | 1.83870858 |
| 20 | JAK3 | 1.83125533 |
| 21 | TAOK3 | 1.80422264 |
| 22 | SIK3 | 1.71126684 |
| 23 | PIK3CG | 1.69424143 |
| 24 | ERN1 | 1.58961729 |
| 25 | IRAK3 | 1.56908603 |
| 26 | MAP3K11 | 1.56492397 |
| 27 | MAP3K1 | 1.49738559 |
| 28 | TBK1 | 1.49321733 |
| 29 | PRPF4B | 1.47634742 |
| 30 | HCK | 1.47577145 |
| 31 | SYK | 1.47444602 |
| 32 | TAOK1 | 1.46256127 |
| 33 | MATK | 1.45131032 |
| 34 | GRK6 | 1.43935153 |
| 35 | KIT | 1.43485640 |
| 36 | BTK | 1.43345477 |
| 37 | EPHB1 | 1.42990090 |
| 38 | JAK1 | 1.37812723 |
| 39 | MAP3K5 | 1.36695311 |
| 40 | JAK2 | 1.36176638 |
| 41 | KSR2 | 1.33427912 |
| 42 | LYN | 1.32310104 |
| 43 | TEC | 1.27380785 |
| 44 | IKBKB | 1.21193674 |
| 45 | MARK3 | 1.20984106 |
| 46 | GRK7 | 1.14104969 |
| 47 | CSF1R | 1.12272459 |
| 48 | MAP3K2 | 1.06205248 |
| 49 | MAP3K13 | 1.06157224 |
| 50 | MAP2K4 | 1.04650027 |
| 51 | RAF1 | 0.98316230 |
| 52 | LCK | 0.94637356 |
| 53 | ITK | 0.93097951 |
| 54 | MARK2 | 0.92866193 |
| 55 | YES1 | 0.88604542 |
| 56 | FRK | 0.84972789 |
| 57 | TESK2 | 0.82274191 |
| 58 | TAOK2 | 0.77816346 |
| 59 | TGFBR2 | 0.77292655 |
| 60 | ARAF | 0.75948148 |
| 61 | MAP2K6 | 0.73450935 |
| 62 | FGFR3 | 0.67658167 |
| 63 | DAPK2 | 0.67458434 |
| 64 | MOS | 0.67335200 |
| 65 | SIK2 | 0.67296210 |
| 66 | PIM2 | 0.65750366 |
| 67 | PDK1 | 0.64039218 |
| 68 | CDK19 | 0.63215290 |
| 69 | KSR1 | 0.62716481 |
| 70 | ACVR1B | 0.62672641 |
| 71 | PTK2B | 0.60809898 |
| 72 | LRRK2 | 0.57868679 |
| 73 | CDK6 | 0.57512782 |
| 74 | RET | 0.54646491 |
| 75 | DYRK1B | 0.53948502 |
| 76 | HIPK2 | 0.52956806 |
| 77 | PRKD2 | 0.51456363 |
| 78 | PIM1 | 0.50480228 |
| 79 | PDPK1 | 0.49882014 |
| 80 | STK10 | 0.47295423 |
| 81 | FYN | 0.44194297 |
| 82 | MAPK7 | 0.42013100 |
| 83 | MAP3K7 | 0.41986140 |
| 84 | WNK1 | 0.39236318 |
| 85 | STK11 | 0.38833786 |
| 86 | CHUK | 0.36050393 |
| 87 | EPHA3 | 0.35157034 |
| 88 | SIK1 | 0.34707034 |
| 89 | PRKCQ | 0.34562332 |
| 90 | ABL1 | 0.34320264 |
| 91 | RPS6KL1 | 0.32130920 |
| 92 | RPS6KC1 | 0.32130920 |
| 93 | RPS6KA6 | 0.30497424 |
| 94 | PRKD1 | 0.30242812 |
| 95 | CDK12 | 0.30077690 |
| 96 | STK24 | 0.29886688 |
| 97 | NLK | 0.26814412 |
| 98 | MAPKAPK2 | 0.25838695 |
| 99 | EGFR | 0.25603342 |
| 100 | SGK2 | 0.24795174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.36205840 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.05360332 |
| 3 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.82354535 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.61644180 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.59516315 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 2.47142156 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.44731520 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.21424352 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03706202 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02303937 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.85913603 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.82552136 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.78484406 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.77561193 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.71892151 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.70836186 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.69689329 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.68830593 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67749751 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.66310544 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60937930 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57021835 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51694486 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.50499763 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49890627 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.44824445 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.39511089 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39026803 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36085896 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35829580 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.34889773 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.32581299 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.32211786 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27783965 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.24369843 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22488019 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21903089 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.19300889 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.16615294 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.13534150 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.12616850 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.11068989 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10200273 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07831800 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07158479 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.06816799 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.05792206 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00921471 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.97999264 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96609621 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.96273790 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91986497 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90766327 |
| 54 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.90666541 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90533655 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.89817230 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88812362 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88762790 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88695167 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88231483 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.87831706 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86912330 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84987462 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.82129902 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76130783 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76109602 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74857525 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73412104 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73368907 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73262296 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70226878 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68909644 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65985626 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62085247 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61710715 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61695324 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60718842 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60208988 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58824275 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54008869 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51733421 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50656048 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50308897 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.49717986 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48456012 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44824556 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44794972 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44103966 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43479735 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.42324030 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41184503 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37092920 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34256179 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32763814 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30888853 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30699024 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30382270 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.30304165 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29011299 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28599225 |

